Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ezetimibe for management of hypercholesterolemia.

Vincent F Mauro1, Chad E Tuckerman

  • 1College of Pharmacy, University of Toledo, Toledo, OH, USA.

The Annals of Pharmacotherapy
|May 30, 2003
PubMed
Summary

Ezetimibe, a novel cholesterol absorption inhibitor, effectively lowers LDL-C when used alone or with statins. Further research is needed to confirm long-term benefits for hypercholesterolemia management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2021
Same author

Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2018
Same author

Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2018
Same author

Physical compatibility of valproate sodium injection with dobutamine and dopamine.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2017
Same author

Role of the Funny Current Inhibitor Ivabradine in Cardiac Pharmacotherapy: A Systematic Review.

American journal of therapeutics·2016
Same author

Compatibility of argatroban injection with select antiarrhythmic drugs.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2014

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Cardiovascular Medicine

Background:

  • Hypercholesterolemia management is crucial for cardiovascular health.
  • Statins are primary agents, but additional therapies are needed.
  • Ezetimibe represents a new class of antihyperlipidemic agents.

Purpose of the Study:

  • To review the pharmacology of ezetimibe.
  • To assess clinical trial data on ezetimibe for hypercholesterolemia.
  • To understand ezetimibe's role in lipid management.

Main Methods:

  • MEDLINE search (1966-2002) using specific keywords.
  • Inclusion of English-language articles and abstracts.
  • Review of articles on ezetimibe's chemistry, pharmacology, and clinical efficacy.

Main Results:

  • Ezetimibe inhibits cholesterol absorption by over 50% in humans.
  • Ezetimibe 10 mg/d reduced LDL-C by ~18% and enhanced statin efficacy by 15-20%.
  • Ezetimibe demonstrated favorable effects on triglycerides and HDL-C with good tolerability.

Conclusions:

  • Ezetimibe shows potential in treating primary hypercholesterolemia.
  • Concurrent use with statins can enhance LDL-C reduction or allow lower statin doses.
  • Further data are required to establish long-term efficacy and cardiovascular outcomes.

Related Experiment Videos